Literature DB >> 27502028

Grey matter density decreases as well as increases in patients with classic galactosemia: A voxel-based morphometry study.

Inge Timmers1, Lisanne D van der Korput2, Bernadette M Jansma3, M Estela Rubio-Gozalbo4.   

Abstract

Brain impairments have been observed in patients with classic galactosemia, an inherited metabolic disorder resulting in a particular neuro-cognitive profile. Neuroimaging studies showed abnormalities such as diffuse white mater (WM) abnormalities and grey matter (GM) atrophy. Our current study analysed grey matter density using voxel-based morphometry (VBM) and compared the brains of eight adolescent patients with classic galactosemia with eight healthy gender- and aged-matched controls. GM density differences were found in several regions. Decreased GM density was found in the patients in the bilateral putamen and bilateral occipital cortex. Increased GM density in the patients, on the other hand, was found in the bilateral inferior frontal and medial prefrontal cortex. The anatomical profile of the abnormalities is in line with the neuro-cognitive profile of patients with classic galactosemia, including motor dysfunction, speech and language difficulties and higher order cognitive problems. Less favourable GM densities in patients (either increased or decreased compared to controls) correlated with younger age, a worse visual working memory performance, and an older age at initiation of the galactose-restricted diet. To conclude, this explorative study is the first to analyse the GM using VBM in this population, and demonstrates a mixed profile of both increased and decreased GM density in these patients.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Classic galactosemia; GALT; Grey matter; Neuroimaging; Voxel-based morphometry

Mesh:

Year:  2016        PMID: 27502028     DOI: 10.1016/j.brainres.2016.08.005

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Assessment of ataxia phenotype in a new mouse model of galactose-1 phosphate uridylyltransferase (GALT) deficiency.

Authors:  Wyman Chen; Rose Caston; Bijina Balakrishnan; Anwer Siddiqi; Kamalpreet Parmar; Manshu Tang; Merry Feng; Kent Lai
Journal:  J Inherit Metab Dis       Date:  2016-10-25       Impact factor: 4.982

2.  Exploration of the Brain in Rest: Resting-State Functional MRI Abnormalities in Patients with Classic Galactosemia.

Authors:  Britt van Erven; Bernadette M Jansma; M Estela Rubio-Gozalbo; Inge Timmers
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

Review 3.  Current and Future Treatments for Classic Galactosemia.

Authors:  Britt Delnoy; Ana I Coelho; Maria Estela Rubio-Gozalbo
Journal:  J Pers Med       Date:  2021-01-28

4.  Abnormal N-glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake.

Authors:  Eileen P Treacy; Sebastian Vencken; Annet M Bosch; Matthias Gautschi; Estela Rubio-Gozalbo; Charlotte Dawson; Darragh Nerney; Hugh Owen Colhoun; Loai Shakerdi; Gregory M Pastores; Roisin O'Flaherty; Radka Saldova
Journal:  JIMD Rep       Date:  2021-07-22

5.  Cognitive functioning in patients with classical galactosemia: a systematic review.

Authors:  Merel E Hermans; Mendy M Welsink-Karssies; Annet M Bosch; Kim J Oostrom; Gert J Geurtsen
Journal:  Orphanet J Rare Dis       Date:  2019-10-18       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.